These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 28508350

  • 1. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
    Bravo PE, Dorbala S.
    Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
    [Abstract] [Full Text] [Related]

  • 2. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.
    Singh V, Falk R, Di Carli MF, Kijewski M, Rapezzi C, Dorbala S.
    J Nucl Cardiol; 2019 Feb; 26(1):158-173. PubMed ID: 30569412
    [Abstract] [Full Text] [Related]

  • 3. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW, van Rheenen RW, van den Berg MP, Noordzij W, Koole M, Blokzijl H, Dierckx RA, Slart RH, Hazenberg BP.
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cardiac scintigraphy with 99mTc-diphosphonates in cardiac amyloidosis.
    de Haro-Del Moral FJ, Pubul-Núñez V, Casáns-Tormo I, Jiménez-Heffernan A, Ruano-Pérez R.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020 Mar; 39(4):254-266. PubMed ID: 32513587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 99m Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.
    Tahara N, Lairez O, Endo J, Okada A, Ueda M, Ishii T, Kitano Y, Lee HE, Russo E, Kubo T.
    ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
    [Abstract] [Full Text] [Related]

  • 13. Molecular imaging of amyloidosis: will the heart be the next target after the brain?
    Chen W, Dilsizian V.
    Curr Cardiol Rep; 2012 Apr; 14(2):226-33. PubMed ID: 22193845
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Monitoring of cardiac transthyretin amyloid load by [99mTc]DPD scintigraphy: is it the end of the semi-quantitative evaluation?
    Minutoli F, Laudicella R, Baldari S.
    Amyloid; 2022 Sep; 29(3):210. PubMed ID: 35321592
    [No Abstract] [Full Text] [Related]

  • 17. Serial 99mTechnetium Pyrophosphate Scintigraphy and Multimodality Assessments After Different Doses of Tafamidis for Variant Transthyretin Cardiac Amyloidosis.
    Okada A, Tateishi E, Morita Y, Ohta-Ogo K, Izumi C.
    Circ Heart Fail; 2023 Jan; 16(1):e009595. PubMed ID: 36541213
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. How to Image Cardiac Amyloidosis: A Practical Approach.
    Dorbala S, Cuddy S, Falk RH.
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1368-1383. PubMed ID: 31607664
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.